Irish-based Medtronic partners with Samsung for new diabetes device
Dublin-headquartered Medtronic has received approval to sell a device for diabetes patients that displays insulin levels on Internet-enabled devices and sends text messages to loved ones if something goes wrong.
The US Food and Drug Administration has approved the company’s MiniMed Connect, a small fob that can be carried in a pocket or hooked on a key chain to transmit information wirelessly from an insulin pump or glucose monitor to a smartphone. The system can send text messages to patients, family members or doctors when something goes awry.
At an industry conference the medical device company also announced a long-term partnership with South Korean technology giant Samsung Electronics Co. to develop secure applications for diabetes management.
The first project in the collaboration will involve the development of mobile applications optimized to display data from Medtronic’s newly approved device, the MiniMed Connect, on Samsung smartphones.
The company’s phones run on the Android operating system, which is used by about 80 percent of mobile phone users, the companies said.
The companies will work together to develop a pipeline of products that address unmet lifestyle and social needs, said Alejandro Galindo, general manager of Medtronic’s intensive insulin management business. Details of the projects and the financial terms of the agreement were not disclosed.